Fractyl Health director granted 22,500 stock options

FRACTYL HEALTH, INC. director Clive Meanwell received a grant of stock options as part of his non-employee director compensation.

Rhea-AI Filing Summary

FRACTYL HEALTH, INC. director Clive Meanwell received a grant of stock options as part of his non-employee director compensation. The award covers 22,500 options for common stock at an exercise price of $0.7318 per share, expiring on June 9, 2036.

The options vest in a single installment on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date, assuming continued service on the board. Following this grant, Meanwell holds 22,500 stock options directly, with no open-market purchases or sales reported.

Insider Trade Summary

Grant/Award: 22,500 shares

Grant/Award 1 txn

Insider MEANWELL CLIVE

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	22,500	$0.00	$0.00

Holdings After Transaction: Stock Option — 22,500 contracts (Direct)

Footnotes (1)

1. F1. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.

Key Figures

Options granted: 22,500 options Exercise price: $0.7318 per share Expiration date: June 9, 2036 +2 more

5 metrics

Options granted 22,500 options Stock option award to director on June 10, 2026

Exercise price $0.7318 per share Strike price for the 22,500 stock options

Expiration date June 9, 2036 Option term for director grant

Underlying shares 22,500 shares Common stock underlying the stock options

Holdings after grant 22,500 options Total options held following this transaction

Key Terms

Stock Option, non-employee director compensation policy, vest and become exercisable, annual meeting of stockholders, +1 more

5 terms

Stock Option financial

"The stock option was awarded as compensation for the Reporting Person's service"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

non-employee director compensation policy financial

"pursuant to the Issuer's non-employee director compensation policy"

vest and become exercisable financial

"The stock option will vest and become exercisable in a single installment"

annual meeting of stockholders financial

"on the earlier of (i) the date of the next annual meeting of stockholders"

grant financial

"the first anniversary of the grant, in each case subject to continued service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did FRACTYL HEALTH (GUTS) director Clive Meanwell report on this Form 4?

Clive Meanwell reported receiving a grant of 22,500 stock options as director compensation. These options give him the right to buy FRACTYL HEALTH common stock at a fixed exercise price if vesting and other conditions are met.

How many FRACTYL HEALTH (GUTS) stock options were granted and at what exercise price?

The filing shows a grant of 22,500 stock options with an exercise price of $0.7318 per share. This means Meanwell can later purchase FRACTYL HEALTH common stock at that price once the options vest and before they expire.

When do Clive Meanwell’s FRACTYL HEALTH (GUTS) stock options vest?

The options vest in a single installment on the earlier of the next annual meeting of stockholders or the first anniversary of the grant. Vesting is conditional on Meanwell continuing to serve as a non-employee director on FRACTYL HEALTH’s board through that date.

What is the expiration date of the FRACTYL HEALTH (GUTS) stock options granted to Clive Meanwell?

The options expire on June 9, 2036, according to the filing. After that expiration date, any unexercised options will lapse, and Meanwell will no longer have the right to buy FRACTYL HEALTH common stock at the stated exercise price.

Did Clive Meanwell buy or sell FRACTYL HEALTH (GUTS) shares in the market in this Form 4?

No open-market purchases or sales are reported in this Form 4. The filing only shows a compensation-related grant of stock options, with 22,500 options awarded and no corresponding market transactions in FRACTYL HEALTH common stock disclosed.

How many FRACTYL HEALTH (GUTS) stock options does Clive Meanwell hold after this grant?

After this grant, the total number of stock options reported as held is 22,500. This figure reflects the options covered by the award described in the Form 4 and represents his reported derivative holdings immediately following the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MEANWELL CLIVE

(Last) (First) (Middle)

3 VAN DE GRAAFF DRIVE

SUITE 200

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FRACTYL HEALTH, INC. [ GUTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.7318	06/10/2026		A		22,500		(1)	06/09/2036	Common Stock	22,500	$0	22,500	D

Explanation of Responses:

1. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.

	/s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)